Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropicalspastic paraparesis

Citation
Em. Maloney et al., Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropicalspastic paraparesis, J INFEC DIS, 181(6), 2000, pp. 2037-2040
Citations number
16
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00221899 → ACNP
Volume
181
Issue
6
Year of publication
2000
Pages
2037 - 2040
Database
ISI
SICI code
0022-1899(200006)181:6<2037:CNSAOT>2.0.ZU;2-F
Abstract
Human T cell lymphotropic virus type I (HTLV-I) is associated with a chroni c neurologic disease called HTLV-I-associated myelopathy/tropical spastic p araparesis (HAM/TSP). The potential mechanisms of HAM/TSP pathogenesis were assessed by examination of 2 pathways initiated by interferon-gamma, a pre dominant cytokine in HAM/TSP. Jamaican HAM/TSP patients (n = 17) were compa red with patients with other neurologic diseases (ONDs; n = 13) with respec t to cerebrospinal fluid levels of the following: neopterin; nitrite plus n itrate, a stable indicator of nitric oxide; and tryptophan and kynurenine, metabolites of the indoleamine-2,3-dioxygenase (IDO) pathway. HAM/TSP patie nts had significantly elevated levels of neopterin (P = .003) and kynurenin e (P = .05) and a significantly decreased level of tryptophan (P = .003), c ompared with patients with ONDs, These results support immune activation wi thin the central nervous system and activation of the IDO pathway. Thus, ac tivation of the IDO pathway may play a role in HAM/TSP.